N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency

Journal of Cardiology

Volumn 55, Issue 3, 2010, Pages 377-383

  Yamashita, Teruyo ^a   Seino, Yoshihiko ^b   Ogawa, Akio ^a   Ogata, Ken ichi ^a   Fukushima, Masato ^a   Tanaka, Keiji ^a   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

Author keywords

Acute coronary syndrome; B type natriuretic peptide; Cardiac emergency; Cardio renal interaction; Heart failure

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BINDING PROTEIN; CREATINE KINASE MB; HEART TYPE FATTY ACID BINDING PROTEIN; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AORTA DISSECTION; ARTICLE; COMPLETE HEART BLOCK; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DYSPNEA; ELECTROCARDIOGRAM; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HOSPITAL; HOSPITAL ADMISSION; HUMAN; KIDNEY FUNCTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PROGNOSIS; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

BIOLOGICAL MARKERS; CHEST PAIN; CREATINE KINASE, MB FORM; CYTOSOL; DYSPNEA; EMERGENCIES; FATTY ACID-BINDING PROTEINS; FEMALE; GLOMERULAR FILTRATION RATE; HEART DISEASES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; STROKE VOLUME; TROPONIN T;

EID: 77952111347     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2010.01.008     Document Type: Article

References (32)

1. Seino Y., Tomita Y., Hoshino K., Setsuta K., and Takano T. Pathophysiological analysis of serum troponin T release kinetics in evolving ischemic myocardial injury. Jpn Circ J 60 (1996) 265-276
2. Seino Y., Ogata K., Takano T., Ishii J., Hishida H., Morita H., Takeshita H., Takagi Y., Sugiyama H., Tanaka T., and Kitaura Y. Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin test. Am J Med 115 (2003) 185-190
3. Setsuta K., Seino Y., Takahashi N., Ogawa T., Sasaki K., Harada A., Takano T., Kishida H., and Hayakawa H. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 84 (1999) 608-611
4. Tanaka K., Seino Y., Ohbayashi K., and Takano T. Cardiac emergency triage and therapeutic decisions using whole blood rapid troponin T test for patients with suspicious acute coronary syndrome. Jpn Circ J 65 (2001) 424-428
5. Taniguchi R., Sato Y., Yamada T., Ooba M., Higuchi H., Matsumori A., Kimura T., and Kita T. Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure. Circ J 68 (2004) 1160-1164
6. Sato Y., Nishi K., Taniguchi R., Miyamoto T., Fukuhara R., Yamane K., Saijyo S., Tanada Y., Yamamoto E., Goto T., Takahashi N., Fujiwara H., and Takatsu Y. In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events. J Cardiol 54 (2009) 221-230
7. Seino Y., Ogawa A., Yamashita T., Fukushima M., Ogata K., Fukumoto H., and Takano T. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail 6 (2004) 295-300
8. Omland T., Persson A., Ng L., O'Brien R., Karlsson T., Herlitz J., Hartford M., and Caidahl K. N-Terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106 (2002) 2913-2918
9. Ogawa A., Seino Y., Yamashita T., Ogata K., and Takano T. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome. Circ J 70 (2006) 1372-1378
10. Weiner D.E., Tabatabai S., Tighiouart H., Elsayed E., Bansal N., Griffith J., Salem D.N., Levey A.S., and Sarnak M.J. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis 48 (2006) 392-401
11. Szczech L.A., Best P.J., Crowley E., Brooks M.M., Berger P.B., Bittner V., Gersh B.J., Jones R., Califf R.M., Ting H.H., Whitlow P.J., Detre K.M., Holmes D., and Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation 105 (2002) 2253-2258
12. Wright R.S., Reeder G.S., Herzog C.A., Albright R.C., Williams B.A., Dvorak D.L., Miller W.L., Murphy J.G., Kopecky S.L., and Jaffe A.S. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 137 (2002) 563-570
13. MacDonagh T.A., Robb S.D., Murdoch D.R., Morton J.J., Ford I., Morrison C.E., Tunstall-Pedoe H., McMurray J.J.V., and Dargie H.J. Biochemical detection of left-ventricular systolic dysfunction. Lancet 351 (1998) 9-13
14. de Lemos J.A., Mcguire J.A., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
15. Yoshimura M., Yasue H., Okumura K., Ogawa H., Jougasaki M., Mukoyama M., Nakao K., and Imura H. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87 (1993) 464-469
16. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., Ogawa H., Okumura K., Mukoyama M., and Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
17. Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 6 (2004) 257-260
18. Costello-Boerrigter L.C., Boerrigter G., Redfield M.M., Rodeheffer R.J., Urban L.H., Mahoney D.W., Jacobsen S.J., Heublein D.M., and Burnett J.C. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community. J Am Coll Cardiol 47 (2006) 345-353
19. Pfister R., Scholz M., Wielckens K., Erdmann E., and Schneider C.A. Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 6 (2004) 289-293
20. Jernberg T., Lindahl B., Siegbahn A., Andren B., Frostfeldt G., Lagerqvist Bo, Stridsberg M., Venge P., and Wallentin L. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 42 (2003) 1909-1916
21. Galvani M., Ferrini D., and Ottani F. Natriuretic peptides for risk stratification of patients with acute coronary syndromes. Eur J Heart Fail 6 (2004) 327-333
22. Jernberg T., Stridsberg M., Venge P., and Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 40 (2002) 437-445
23. Heeschen C., Hamm C.W., Mitrovic V., Lantelme N.H., White H.D., and for the Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110 (2004) 3206-3212
24. Masson S., Latini R., Anand I.S., Vago T., Angelici L., Barlera S., Missov E.D., Clerico A., Tognoni G., and Cohn J.N. Val-HeFT Investigators. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Clin Chem 52 (2006) 1528-1538
25. McCullough P.A., and Sandberg K.R. Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med 4 Suppl 4 (2003) S13-S19
26. Anwaruddin S., Lloyd-Jones D.M., Baggish A., Chen A., Krauser D., Tung R., Chae C., and Januzzi J.L. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement. J Am Coll Cardiol 47 (2006) 91-97
27. De Filippi C.R., Fink J.C., Nass C.M., Chen H., and Christenson R. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. Am J Kidney Dis 46 (2005) 35-44
28. Seino Y., Shimai S., Tanaka K., Takano T., and Hayakawa H. Cardiovascular circulatory adjustments and renal function in acute heart failure. Jpn Circ J 53 (1989) 180-190
29. Hillege H.L., Girbes A.R.J., de Kam P.J., Boomsma F., de Zeeuw D., Charlesworth A., Hampton J.R., and van Veldhuisen D.J. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102 (2000) 203-210
30. James S.K., Lindahl B., Siegbahn A., Stridsberg M., Venge P., Armstrong P., Barnathan E.S., Califf R., Topol E.J., Simoons M.L., and Wallentin L. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. A global utilization of strategies to open occluded arteries (GUSTO)-IV substudy. Circulation 108 (2003) 275-281
31. Luchner A., Hengstenberg C., Lowel H., Trawinski J., Baumann M., Riegger G.A.J., Schunkert H., and Holmer S. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function. Hypertension 39 (2002) 99-104
32. van Kimmenade R.R.J., Januzzi J.L., Baggish A.L., Lainchbury J.G., Bayes-Genis A., Richards A.M., and Pint Y.M. Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure. J Am Coll Cardiol 48 (2006) 1621-1627